QO 58
Tocris Bioscience, part of Bio-Techne | Catalog # 5083
Kv7 channel opener
Key Product Details
Description
Kv7 channel opener
Product Description
QO 58 is a Kv7 channel opener (EC50 values are 0.6, 1.0, 5.2 and 7.0 μM for Kv7.4, Kv7.2, Kv7.3/7.5 and Kv7.1, respectively). Increases the pain threshold of neuropathic pain in a sciatic nerve CCI in vivo model.Product Specifications
Molecular Weight
443.18
Formula
C18H8Cl2F4N4O
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
5-(2,6-Dichloro-5-fluoro-3-pyridinyl)-3-phenyl-2-(trifluoromethyl)-pyrazolo[1,5-a]pyrimidin-7(4H)-one
CAS Number
1259536-62-3
PubChem ID
51351551
InChI Key
ZOLHKPWSDFSDKA-UHFFFAOYSA-N
SMILES
O=C1C=C(C4=CC(F)=C(Cl)N=C4Cl)NC2=C(C3=CC=CC=C3)C(C(F)(F)F)=NN12
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 22.16 | 50 |
Preparing Stock Solutions
for QO 58
The following data is based on the product molecular weight 443.18
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 4.51 mL | 22.56 mL | 45.13 mL |
| 2.5 mM | 0.90 mL | 4.51 mL | 9.03 mL |
| 5 mM | 0.45 mL | 2.26 mL | 4.51 mL |
| 25 mM | 0.09 mL | 0.45 mL | 0.90 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Qi Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators. Eur.J.Med.Chem. 2011 PMID: 21296466
- Zhang Modulation of Kv7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58. Br.J.Pharmacol. 2013 PMID: 23013484
Product Specific Notices for QO 58
For research use only
Loading...
Loading...
Loading...